Nuclear Medicine and Biology
Volume 36, Issue 4 , Pages 363-369 , May 2009

Radiolabeling of trastuzumab with 177Lu via DOTA, a new radiopharmaceutical for radioimmunotherapy of breast cancer

  • Samira Rasaneh

      Affiliations

    • Department of Medical Physics, Tarbiat Modares University, Tehran, Iran
    • ,
  • Hossein Rajabi

      Affiliations

    • Department of Medical Physics, Tarbiat Modares University, Tehran, Iran
    • Corresponding Author InformationCorresponding author. Tel.: +98 21 82883894; fax: +98 21 88006544.
    • ,
  • Mohammad Hossein Babaei

      Affiliations

    • Department of Radioisotope, Nuclear Science and Technology Research Institute, Tehran, Iran
    • ,
  • Fariba Johari Daha

      Affiliations

    • Department of Radioisotope, Nuclear Science and Technology Research Institute, Tehran, Iran
    • ,
  • Mojtaba Salouti

      Affiliations

    • Department of Biology, School of Sciences, Islamic Azad University - Zanjan Branch, Zanjan, Iran

Received 20 October 2008 ,Revised 18 January 2009 ,Accepted 31 January 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(09)00039-0

doi: 10.1016/j.nucmedbio.2009.01.015

Nuclear Medicine and Biology
Volume 36, Issue 4 , Pages 363-369 , May 2009

Article Tools

* Image Usage & Resolution